IBA Reports Full Year 2019 Results

Thursday, March 26, 2020 - 17:15
Industrial Solutions
STRONG ORDER INTAKE AND RECORD BACKLOG ACROSS ALL BUSINESS LINES
SIGNIFICANTLY STRENGTHENED BALANCE SHEET
Olivier Legrain, Chief Executive Officer of IBA commented: “At IBA’s core is our deep, world leading expertise in particle acceleration. This unrivalled understanding combined with more than 30 years of operational application has seen IBA build four robust business lines: Proton Therapy, Dosimetry, Radiopharma and Industrial Solutions...READ MORE
Back to news